Microdosing for Depression and Anxiety: What the Clinical Evidence Actually Shows
Placebo-controlled trials of microdosing have consistently failed to show that low doses of psilocybin or LSD outperform placebo for mood, anxiety, or well-being. People taking a...
Microdosing Protocols in 2026: Fadiman, Stamets, and the Clinical Data
The two most widely followed microdosing protocols are the Fadiman protocol (one day on, two days off) and the Stamets Stack (four or five days on,...
Psychedelic Therapy in Washington State: Legal Status and Access
Psychedelic therapy in Washington state is an evolving picture. Ketamine is fully legal and widely available across Seattle and the broader Puget Sound area. Psilocybin remains...
Executive Burnout Psychedelic Therapy: What the Research Shows
Executive burnout psychedelic therapy is moving from the research margins into serious clinical conversation. A growing body of peer-reviewed evidence suggests that psilocybin-assisted therapy can reduce...
Microdosing Psychedelics — Promise, Risks, and Where We Go from Here
Quick answer: Microdosing psychedelics means taking very small, sub-perceptual doses of substances such as psilocybin or LSD, usually on a repeated schedule rather than in a...
Microdosing with Ayahuasca: An Emerging Practice
Microdosing ayahuasca means taking sub-perceptual amounts of the traditional Amazonian brew to support mood, clarity, and emotional processing without a full ceremonial experience. The formal research...
Ready to take the next step?
Start with a complimentary conversation, or take the two-minute self-evaluation to see if this is your moment.